Skip to main content
. 2012 Jan 21;18(3):212–224. doi: 10.3748/wjg.v18.i3.212

Figure 4.

Figure 4

Insulin resistance predicts response to peginterferon-α/ribavirin combination therapy in chronic hepatitis C patients[106]. 1Statistical significance. SVR: Sustained virological response; HOMA-IR: Homeostasis model assessment-insulin resistance.